Regulation of Protein Synthesis and Erythropoiesis
Regulation of Protein Synthesis and Erythropoiesis
批准号:
6829082
负责人:
JANE-JANE CHEN
金额:
$38.89万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-01-01 至 2007-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Our long-term objective is to contribute to the understanding of the regulation of hemoglobin synthesis and erythroid differentiation in normal and abnormal hematological conditions, with particular emphasis on the roles of heme and protein synthesis in these processes. Protein synthesis in intact reticulocytes and their lysates is dependent on the availability of heme. Heme serves as the prosthetic group of the hemoglobin, the predominant protein in red blood cell (RBC) and its late precursor cells. Biochemical studies have shown that, under conditions of heine-deficiency or iron-deficiency, protein synthesis is inhibited at the level of initiation due to the activation of the heme-regulated translational inhibitor (HRI). HRI is a heme-regulated protein kinasc that phosphorylates the ct-subunit of eukaryotic initiation factor 2 (eIF2a). Phosphorylation of the ct-subunit of eIF2 impairs its recycling in translational initiation and results in the cessation of protein synthesis. The research designs are (1) To Elucidate the Molecular Mechanism by which HRI Regulates Red Blood Cell Production, (2) To Assess the Protective Role of HRI in Red Blood Cell Disorders, and (3) To Delineate the Molecular Mechanism of Stress-Activation of HRI. The methods to be employed are the generation of genetically modified mice, hematological analysis, histological and electron microscopic examinations, colony culture assays for erythroid progenitors, Western-blot analysis and protein kinase assays, cell culture, phenotypic examination of mouse embryos, recombinant DNA techniques. Our recent study indicate that HRI is not only necessary for globin synthesis, but also for heine biosynthesis. HRI is also important for the survival of mice with thalassemia and erythropoietic protoporphria. Our proposed study may lead to potential application of HRI in treating human patients with red cell diseases. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:7863731
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8703304
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:8279410
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:9243242
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8729681
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8829233
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:8110587
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:8099953
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7903778
-
项目类别:
-
资助金额:$8.91万
-
财政年份:2009
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7674587
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2008
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7470479
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2008
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:6350684
-
项目类别:
-
资助金额:$21.56万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:2446303
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:6150559
-
项目类别:
-
资助金额:$20.93万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:2872246
-
项目类别:
-
资助金额:$20.68万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:7168818
-
项目类别:
-
资助金额:$36.88万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:2136998
-
项目类别:
-
资助金额:$29.9万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:6176508
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:2900122
-
项目类别:
-
资助金额:$29.49万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:6688995
-
项目类别:
-
资助金额:$38.89万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
抑制Protein Kinase D促进胚胎干细胞自我更新的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:叶守东
-
依托单位:
C2 DOMAIN PROTEIN 1 (C2DP1)基因家族在植物开花调控中的功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
凡纳滨对虾Laccase-like protein非酶活依赖参与抗WSSV免疫的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:史黎黎
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
玉米基因Dirigent protein 4的克隆和功能鉴定
-
批准号:32101754
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:秦涛
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
锌指蛋白33B(Zinc finger protein 33B, ZNF33B)抑制乙型脑炎病毒复制的功能与分子机制研究
-
批准号:32072901
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李祥敏
-
依托单位:
锌指蛋白33B(Zinc finger protein 33B, ZNF33B)抑制乙型脑炎病毒复制的功能与分子机制研究
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2020
-
负责人:李祥敏
-
依托单位: